Research findings indicate that the CXCL12 and STAT3 proteins are significantly upregulated in various malignancies, including breast cancer, lung cancer, hepatocellular carcinoma, esophageal cancer, bladder cancer, and leukemia [78,79,80]. Here, CXCL12 is linked to hepatocellular carcinoma.